Indo US Bio Tech Ltd Stock Price Today (NSE: INDOUS)

Indo US Bio Tech Ltd

90.47+1.28 (+1.44%)
Market Closed

Fundamental Score

...

Indo US Bio Tech Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Indo US Bio Tech Ltd share price today is 90.47, up +1.44% on NSE/BSE as of 17 June 2026. Indo US Bio Tech Ltd (INDOUS) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of 251.38 (Cr). The 52-week high for INDOUS share price is 206.00 and the 52-week low is 96.05. At a P/E ratio of 14.89x, INDOUS is currently trading below its industry average P/E of 21.07x. The company has a Return on Equity (ROE) of 23.03% and a debt-to-equity ratio of 0.32.

Indo US Bio Tech Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
114.00
Low
90.47
Volume
16.2K
Change
-3.42%

Indo US Bio Tech Ltd share price chart: -3.42% return over the past month. 52-week high ₹206.00, 52-week low ₹96.05.

Indo US Bio Tech Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
102.20102.2096.8597.9037.58K (Cr)
98.00103.8498.0099.7618.07K (Cr)
102.98103.1298.1399.809.99K (Cr)
103.40103.4099.95100.5812.87K (Cr)
103.40103.4299.3299.9212.84K (Cr)
103.90103.90100.50100.6113.29K (Cr)
103.90103.94100.27100.9513.20K (Cr)
103.88104.56100.26101.6739.93K (Cr)
101.10104.45101.10101.9110.02K (Cr)
102.00107.50100.05101.7913.91K (Cr)

Indo US Bio Tech Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
98.00103.8496.8597.90-0.10%
106.95114.0098.1399.80-6.69%
99.00112.0099.00104.27+5.32%
142.94148.0096.0598.21-31.29%
120.00154.39120.00144.56+20.47%
124.00133.00105.00125.22+0.98%
133.42151.00118.00121.56-8.89%
135.35159.00109.50135.42+0.05%
140.00144.59119.39134.31-4.06%
151.17154.58130.00132.68-12.23%
170.50182.10148.00149.14-12.53%
156.15206.00144.98174.30+11.62%

Returns & Performance

Excellent

Return on Equity (ROE)

23.03%

Profit generated per ₹1 of shareholder equity

Excellent

Return on Capital (ROCE)

21.15%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

15.82%

Average operating profit margin over 5 years

Dividend Yield

0.20%

Annual dividend as % of current share price

Indo US Bio Tech Ltd Valuation Check

Good

Price to Earnings (P/E)

14.89x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

21.07x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

70.17%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-20.87%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

39.15%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

21.17%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

35.88%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

44.98%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.32x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

12.44x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-3.86 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Indo US Bio Tech Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of INDOUS across key market metrics for learning purposes.

Positive Indicators

11 factors identified

Strong Return on Equity (23.03%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (21.15%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (15.82%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Attractive Valuation (P/E: 14.89 vs Industry: 21.07)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Strong Revenue Growth (39.15%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (21.17% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Excellent EPS Growth (35.88% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (44.98% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Strong Interest Coverage (12.44x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (70.17%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

2 factors identified

Profit Decline Concern (-20.87%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Negative Free Cash Flow (₹-3.86 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Indo US Bio Tech Ltd vs Other Agricultural Products Peers

Peer Comparison - Other Agricultural Products

Compare Indo US Bio Tech Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
65/100
90
₹251.38
14.9
Average
23.03%
Excellent
21.15%
Excellent
0.3
Excellent
44.98%
Excellent
21.17%
Excellent
0.20%
LT Foods Ltd...
LTFOODS532783
67.8/100
405
₹14419.68
22.7
Average
16.70%
Good
19.18%
Good
0.4
Excellent
26.37%
Excellent
15.99%
Excellent
0.72%
KRBL Ltd...
KRBL530813
54.6/100
360
₹9182.57
15.1
Average
9.42%
Poor
11.84%
Average
0.0
Excellent
-3.15%
Poor
4.45%
Average
0.87%
44.1/100
160
₹5195.38
25.2
Average
8.59%
Poor
11.46%
Average
0.1
Excellent
10.42%
Good
3.86%
Average
0.22%
56.1/100
900
₹5132.36
16.9
Average
19.04%
Good
20.08%
Excellent
0.0
Excellent
3.36%
Average
5.30%
Good
0.50%
48.3/100
158
₹2915.20
43.0
Average
16.03%
Good
13.50%
Average
0.4
Excellent
13.84%
Good
12.44%
Good
0.00%
Sanstar Ltd...
SANSTAR544217
45.7/100
115
₹1641.27
81.7
Average
9.63%
Poor
11.76%
Average
0.0
Excellent
129.68%
Excellent
29.55%
Excellent
0.00%
42.3/100
280
₹1277.19
13.6
Average
14.19%
Average
16.71%
Good
0.1
Excellent
14.42%
Good
13.39%
Good
0.97%
52.7/100
98
₹1096.07
39.5
Average
28.81%
Excellent
21.16%
Excellent
0.3
Excellent
58.19%
Excellent
28.28%
Excellent
0.00%
57.2/100
69
₹1038.52
16.9
Average
9.89%
Poor
12.84%
Average
0.2
Excellent
7.46%
Good
7.00%
Good
1.03%
45.7/100
178
₹838.46
19.6
Average
3.92%
Poor
6.31%
Poor
0.7
Good
2.79%
Average
26.61%
Excellent
0.22%

Indo US Bio Tech Ltd PE Ratio History

Historical price-to-earnings ratio for INDOUS — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20258.12₹121.5615x
FY 20244.11₹314.9076.6x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Indo US Bio Tech Ltd Dividend History

Annual cash dividends paid by INDOUS — dividend yield 0.20%

Financial YearDividends Paid (₹ Cr)
FY 20250.50 Cr
FY 20220.15 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Indo US Bio Tech Ltd Quarterly Performance

Latest quarterly metrics for INDOUS — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

39.15%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-20.87%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

21.17%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

44.98%

Compounded annual net profit growth over 5 years

Indo US Bio Tech Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for INDOUS — calculated from daily price history

6RSI 14
Oversold — RSI 6

Selling pressure is heavy — potential reversal zone.

SMA 50
104
▼ Price below SMA 50 — Short-term bearish
SMA 200
127
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
17K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Indo US Bio Tech Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Indo US Bio Tech Ltd (INDOUS) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Indo US Bio Tech Ltd

About INDOUS (Indo US Bio Tech Ltd)

Indo US Bio Tech Ltd is a pioneering force in India's agricultural landscape, specializing in the creation and distribution of high-quality seeds. The company meticulously oversees... every stage, from the initial cultivation and careful processing to the specialized packaging and strategic marketing of its diverse seed portfolio. INDOUS is committed to providing farmers with superior genetic resources, ensuring bountiful harvests and contributing to the nation's food security. They are the backbone of farming communities, constantly innovating to meet the evolving needs of the agricultural industry and setting new standards for seed excellence. Offering a wide spectrum of seed varieties, INDOUS caters to the diverse needs of Indian farmers. Their extensive selection includes a vibrant array of vegetable seeds, from the staple tomato and okra to the more exotic bottle gourd and bitter gourd. In addition to vegetables, INDOUS cultivates and distributes seeds for essential cash crops such as cotton, and vital oilseeds including castor, groundnut, and soybean. The company's commitment to research and development ensures that these seeds are not only high-yielding but also resilient to various environmental challenges, supporting sustainable agricultural practices across the country. Beyond simply selling seeds, INDOUS provides a comprehensive support system for farmers. They believe in empowering the agricultural community through knowledge sharing and innovative solutions. By offering access to premium seeds and practical expertise, INDOUS helps farmers increase their productivity, improve crop quality, and enhance their overall livelihoods. The company actively participates in initiatives that promote sustainable farming practices, contributing to a greener and more prosperous future for Indian agriculture.

Company Details

Symbol:INDOUS
Industry:Other Agricultural Products
Sector:Other Agricultural Products

Key Leadership

Mr. Jagdishkumar Devjibhai Ajudia
Chairman & MD
Ms. Rinku Dipenbhai Jethva
Chief Finance Officer
Ms. Dimpy Divyangbhai Joshi
Company Secretary & Compliance Officer

INDOUS Share Price: Frequently Asked Questions

What is the current share price of Indo US Bio Tech Ltd?

Indo US Bio Tech Ltd (INDOUS) trades at ₹90.47 on NSE and BSE. Market cap ₹251.38 (Cr). Educational data only.

What is the P/E ratio of Indo US Bio Tech Ltd?

Indo US Bio Tech Ltd has a P/E of 14.89x vs industry average 21.07x.

What is the Bull Run score for Indo US Bio Tech Ltd?

Indo US Bio Tech Ltd has a Bull Run score of 65/100 based on 25+ financial parameters.

Does Indo US Bio Tech Ltd pay dividends?

Indo US Bio Tech Ltd has a dividend yield of 0.20%. Past dividends don't guarantee future payments.

What is the ROE of Indo US Bio Tech Ltd?

Indo US Bio Tech Ltd has ROE of 23.03%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Indo US Bio Tech Ltd?

Indo US Bio Tech Ltd has debt-to-equity of 0.32.

Is Indo US Bio Tech Ltd a good investment?

Bull Run gives Indo US Bio Tech Ltd a score of 65/100. This is not investment advice — consult a SEBI-registered advisor.